Orion Genomics LLC
Records under this name other than the patents Orion Genomics LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,633,715 | Gene controlling shell phenotype in palm Formerly held In force (reinstated) · From the USPTO record | In force (reinstated) | From the USPTO record | |
| US 10,905,061 | Mads-Box Domain Alleles for Controlling Shell Phenotype in Palm Formerly held In force · High confidence | In force | High confidence | |
| US 8,088,581 | Differential enzymatic fragmentation by whole genome amplification Term ended Term ended Apr 13, 2026 · From the USPTO record | Term ended | Term ended Apr 13, 2026 | From the USPTO record |
| US 7,459,274 | Differential enzymatic fragmentation by whole genome amplification Term ended Term ended Dec 26, 2025 · From the USPTO record | Term ended | Term ended Dec 26, 2025 | From the USPTO record |
| US 8,361,719 | Methods for quantitative determination of methylation density in a DNA locus Lapsed on the fee record Ended Jan 29, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jan 29, 2025 | From the USPTO record |
| US 8,163,485 | Differential enzymatic fragmentation Lapsed on the fee record Ended Apr 24, 2024 · From the USPTO record | Lapsed on the fee record | Ended Apr 24, 2024 | From the USPTO record |
| US 7,910,296 | Methods for quantitative determination of methylation density in a DNA locus Lapsed on the fee record Ended Mar 22, 2023 · From the USPTO record | Lapsed on the fee record | Ended Mar 22, 2023 | From the USPTO record |
| US 7,901,880 | Differential enzymatic fragmentation Lapsed on the fee record Ended Mar 8, 2023 · From the USPTO record | Lapsed on the fee record | Ended Mar 8, 2023 | From the USPTO record |
| US 9,984,200 | Mantle phenotype detection in palm Formerly held Lapsed on the fee record Ended May 29, 2022 · From the USPTO record | Lapsed on the fee record | Ended May 29, 2022 | From the USPTO record |
| US 8,420,315 | Single nucleotide polymorphisms and combinations of novel and known polymorphisms for determining the allele-specific expression of the IGF2 gene Lapsed on the fee record Ended Apr 16, 2021 · From the USPTO record | Lapsed on the fee record | Ended Apr 16, 2021 | From the USPTO record |